Novavax, Inc. (NVV1.F)
Develops vaccines for COVID-19 and malaria using a protein-based technology platform
6.44-0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+15.3%
The outlook
Novavax is trading near the lower end of its 52-week range, well below both its 50- and 200-day moving averages. Analyst sentiment appears weak, with a bearish score of 14/100. The stock is positioned in a downtrend relative to recent technical levels.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range22% of the way from its 52-week low to high
Market cap
$1.06B
52-wk high
10.03
52-wk low
5.41
50-day avg
7.96
200-day avg
7.28
Trailing P/E
—